E-LIB Suche - Ergebnisse für: Do, Pascal

1

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small..:

Descourt, Renaud ; Pérol, Maurice ; Rousseau-Bussac, Gaëlle...
Cancers. 14 (2022) 7 - p. 1751 , 2022

Link: https://doi.org/10.3390/..

2

Efficacy of Dabrafenib Plus Trametinib Combination in Patie..:

Auliac, Jean-Bernard ; Bayle, Sophie ; Do, Pascal...
Cancers. 12 (2020) 12 - p. 3608 , 2020

Link: https://doi.org/10.3390/..

3

Non-Small Cell Lung Cancer Patients Harboring HER2 Mutation..:

Auliac, Jean-Bernard ; Dô, Pascal ; Bayle, Sophie...
Advances in Therapy. 36 (2019) 8 - p. 2161-2166 , 2019

Link: https://doi.org/10.1007/..

4

Brigatinib in patients with ALK-positive advanced non-small..:

Descourt, Renaud ; Perol, Maurice ; Rousseau-Bussac, Gaëlle...
Lung Cancer. 136 (2019) - p. 109-114 , 2019

Link: https://doi.org/10.1016/..

5

Management and outcomes of non–small cell lung cancer patie..:

Vergnenegre, Alain ; Geier, Margaux ; Guisier, Florian...
Cancer Medicine. 9 (2019) 2 - p. 432-439 , 2019

Link: https://doi.org/10.1002/..

6

Phase II study assessing the benefit of cisplatin re-introd..:

Bennouna, Jaafar ; Barlesi, Fabrice ; Do, Pascal...
ESMO Open. 3 (2018) 5 - p. e000394 , 2018

Link: https://doi.org/10.1136/..

7

Safety of combined PD‐1 pathway inhibition and radiation th..:

Lesueur, Paul ; Escande, Alexandre ; Thariat, Juliette...
Cancer Medicine. 7 (2018) 11 - p. 5505-5513 , 2018

Link: https://doi.org/10.1002/..

8

Why harmonization is needed when using FDG PET/CT as a prog..:

Houdu, Benjamin ; Lasnon, Charline ; Licaj, Idlir...
European Journal of Nuclear Medicine and Molecular Imaging. 46 (2018) 2 - p. 421-428 , 2018

Link: https://doi.org/10.1007/..

9

Correction to: Why harmonization is needed when using FDG P..:

Houdu, Benjamin ; Lasnon, Charline ; Licaj, Idlir...
European Journal of Nuclear Medicine and Molecular Imaging. 46 (2018) 2 - p. 533-534 , 2018

Link: https://doi.org/10.1007/..

10

P3.02b-064 Time to EGFR-TKI Treatment for Patients with Adv..:

Le Guévelou, Jennifer ; Dugué, Audrey ; Richard, Nicolas...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1229 , 2017

Link: https://doi.org/10.1016/..

11

P1.07-008 Lomustine Endoxan VP16 as Second or Further Line ..:

Naltet, Charles ; Dugué, Audrey ; Dubos, Catherine...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S700 , 2017

Link: https://doi.org/10.1016/..

12

P3.02b-127 NSCLC Patients Harboring HER2 Mutation: Clinical..:

Auliac, Jean Bernard ; Do, Pascal ; Bayle, Sophie...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1271 , 2017

Link: https://doi.org/10.1016/..

13

Cost-Effectiveness Analysis of Afatinib versus Gefitinib fo..:

Chouaid, Christos ; Luciani, Laura ; LeLay, Katell...
Journal of Thoracic Oncology. 12 (2017) 10 - p. 1496-1502 , 2017

Link: https://doi.org/10.1016/..

14

P3.02b-013 Evaluation of Lung Specific GPA Score in Adenoca..:

Kao, William ; Dugué, Audrey ; Dô, Pascal...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1193 , 2017

Link: https://doi.org/10.1016/..

15

P3.02b-051 Outcome of Advanced EGFR-Mutated NSCLC Patients ..:

Baldacci, Simon ; Mazieres, Julien ; Tomasini, Pascale...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1219-S1220 , 2017

Link: https://doi.org/10.1016/..